Dipexium Pharmaceuticals, LLC IPO Research Information

Dipexium Pharmaceuticals, LLC IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Dipexium Pharmaceuticals, LLC, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Dipexium Pharmaceuticals, LLC	DPRX - NASDAQ	$12.00-$14.00	$12.00	$14.60	2.75 million	3/13/2014
Underwriter(s): Oppenheimer & Co., Feltl & Co.
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2014-02-06

Dipexium Pharmaceuticals, LLC Quote & Chart - Click for current quote - DPRX

About Dipexium Pharmaceuticals, LLC (adapted from Dipexium Pharmaceuticals, LLC prospectus):
They are a late stage biotech developing a novel antibiotic treatment for diabetic foot ulcers.

This description is adapted from Dipexium DPRX prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Dipexium DPRX "DPRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.